BioCentury
ARTICLE | Clinical News

NNZ-2566: Phase Ib data

November 12, 2007 8:00 AM UTC

Neuren Pharmaceuticals Ltd. (ASX:NEU), Auckland, New Zealand Product: NNZ-2566 Business: Inflammation Molecular target: Not available Description: Small molecule analog of glycine-proline-glutamate, ...